SCHEMBL321624

SCHEMBL321624

CC(=O)OC(C(=O)O)C(OC(C)=O)C(=O)OCC(O)CO

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.39
DUSP3 P51452 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 1/20 0.39
DGKA P23743 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
FAAH O00519 2/20 0.33
PRKCA P17252 2/20 0.33
OR51E2 Q9H255 1/20 0.30
TSHR P16473 1/20 0.30
MMP1 P03956 1/20 0.30
MMP2 P08253 1/20 0.30
MMP3 P08254 1/20 0.30
MMP9 P14780 1/20 0.30
MMP13 P45452 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycerin SCHEMBL6867192 0.85 LMNA (0.39) LMNATDP1PRKCAOR51E2TSHR
SCHEMBL27926540 0.84 KDM4E (0.33) KDM4EDUSP3MEN1KMT2ALMNA
Glyceryl Monostearate SCHEMBL8492217 0.78 LMNA (0.74) KDM4EDUSP3MEN1KMT2ALMNA
Lactic Acid SCHEMBL28793699 0.77 TP53 (0.42) KDM4EDUSP3MEN1KMT2ALMNA
Lactic Acid SCHEMBL28460211 0.76 TP53 (0.46) KDM4EDUSP3MEN1KMT2ALMNA
Acetic Acid SCHEMBL11226370 0.75 LMNA (0.47) KDM4EDUSP3MEN1KMT2ALMNA
Acetic Acid SCHEMBL27581074 0.75 LMNA (0.47) KDM4EDUSP3MEN1KMT2ALMNA
Acetic Acid SCHEMBL25206 0.75 LMNA (0.47) KDM4EDUSP3MEN1KMT2ALMNA
Bicarbonate SCHEMBL3708813 0.75 LMNA (0.47) KDM4EDUSP3MEN1KMT2ALMNA
Acetic Acid SCHEMBL27683881 0.75 LMNA (0.47) KDM4EDUSP3MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023190295-A1 LIQUID NUTRITIONAL COMPOSITION AND PACKAGE ニュートリー株式会社 2023-10-05 WO claimed
CN-113875867-A Milk-containing coffee beverage and preparation method thereof 广州市东鹏食品饮料有限公司 2022-01-04 CN claimed
CN-106068080-A Beverage emulsifying agent containing milk composition 理研维他命股份有限公司 2016-11-02 CN claimed
CN-103432091-A Improved-performance tablet and preparation method thereof ZHONG SHUGUANG 2013-12-11 CN claimed
WO-2010112965-A1 ISOLATION COATING OF DICLOFENAC TABLETS ABDI IBRAHIM ILAC SANAYI VE TICARET ANONIM SIRKETI (TR) 2010-10-07 WO claimed
CN-1891080-A Meat quality-improving agent RIKEN VITAMIN CO (JP) 2007-01-10 CN claimed
US-6818244-B2 LOW-TEMPERATURE, HIGH SPEED REACTION OF A DIACETYLATED TARTARIC ACID ANHYDRIDE MELT AND A MELT OF PARTIAL GLYCERIDES COMPRISING 60-99% MONOGLYCERIDES; EMULSIFIER, DOUGH CONDITIONER FOR FLOUR AND YEAST-LEAVENED BAKERY GOODS QUEST INTERNATIONAL B.V. (NL) 2004-11-16 US claimed
US-6642278-B1 Emulsifiers, dough conditioning, baked goods QUEST INTERNATIONAL B.V. (NL) 2003-11-04 US claimed
US-6635299-B1 Emulsifier for baked goods QUEST INTERNATIONAL B.V. (NL) 2003-10-21 US claimed
US-20030162893-A1 Diacetyl tartaric acid esters of mono- and dig1ycerides based on C12 to C22 fatty acids QUEST INTERNATIONAL B.V. (NL) 2003-08-28 US claimed
EP-1016647-B1 Diacetyl tartaric acid esters of mono- and diglycerides based on C12 to C22 fatty acids QUEST INT (NL) 2003-05-28 EP claimed
EP-0737425-B1 Oil-in-water emulsion containing lysophospholipo-proteins ASAHI DENKA KOGYO KK (JP) 2001-09-12 EP claimed
WO-2000040542-A1 DIACETYL TARTARIC ACID ESTERS OF MONO- AND DIGLYCERIDES BASED ON C12 TO C22 FATTY ACIDS QUEST INTERNATIONAL B.V. (NL) 2000-07-13 WO claimed
EP-1016647-A1 Diacetyl tartaric acid esters of mono- and diglycerides based on C12 to C22 fatty acids QUEST INTERNATIONAL B.V. (NL) 2000-07-05 EP claimed
WO-2024071966-A1 COMPOSITION FOR DELAYING RANCIDITY OF OIL AND OILS COMPRISING SAME 씨제이제일제당 (주) 2024-04-04 WO disclosed
EP-3589280-B1 FORMULATIONS WITH IMPROVED STABILITY INSPIRNA INC (US) 2024-02-07 EP disclosed
US-20240025870-A1 PKC-ACTIVATING COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES Synaptogenix, Inc. (US) 2024-01-25 US disclosed
JP-2000060495-A OIL OR FAT COMPOSITION FOR PROCESSED FISH FOOD AND PROCESSED FISH FOOD RIKEN VITAMIN CO LTD 2000-02-29 JP disclosed
US-5690986-A MIXTURE OF EMULSIFIER, LYSOPHOSPHOLIPOPROTEIN, ANOTHER PROTEIN, OIL AND WATER ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1997-11-25 US disclosed
EP-0737425-A1 Oil-in-water emulsion containing lysophospholipo-proteins ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1996-10-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240025870-A1 PKC-ACTIVATING COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES PRKCH, PRKCA, PRKCG KDM4E 2461/4885DUSP3 1227/4885MEN1 4646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.